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AIMS 
 The primary aim of this study was to determine the prevalence of vitamin B12 
deficiency among vegetarian out patients, between the age groups of 18 and 60 years, 
visiting the internal medicine out patient department of a tertiary level teaching hospital 
in South India, and to study their clinical profile along with the risk factors and clinical 
associations of this condition. 
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OBJECTIVES 
 The study was designed to accomplish the following six objectives: 
 
A] To determine the prevalence of vitamin B12 deficiency among vegetarian patients 
(between the ages of eighteen and sixty years) coming to the internal medicine out patient 
department of Christian Medical College and Hospital, Vellore. 
 
B] To study the clinical manifestations of vitamin B12 deficiency in vegetarians.  
 
C] To study the risk factors associated with the development of vitamin B12 deficiency 
among vegetarians. 
  
D] To study the awareness of vegetarians about vitamin B12 deficiency and the need for 
exogenous supplementation. 
 
E] To study the different neuropsychiatric manifestations and the anxiety and the 
depression levels of the vitamin B12 deficient population 
 
F] To make a preliminary observation as to the prevalence of surrogate markers for 
pernicious anaemia in the study population. 
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INTRODUCTION 
 Vitamin B12 is an essential nutrient that is used by the body to act as cofactors in 
certain key reactions within the cells. Cobalamin along with folate is needed for synthesis 
of DNA required in cells undergoing rapid turnover, such as haematopoetic and enteric 
lining cells. The physiological consequences of a deficiency in any of the above nutrients 
are increased homocysteine, reduced methionine and impaired formation of 
tetrahydrofolate. These changes ultimately lead to the characteristic neurological and 
haematological manifestations, not to mention certain events like vascular thromboses 
that may be seen even in the absence of overt vitamin B12 deficiency. 
 Animal products provide the only dietary source of vitamin B12. Vegetarianism is 
a well known risk factor for vitamin B12 deficiency. Other important etiological 
considerations are pernicious anaemia and malabsorption. 
 The treatment is simply supplementing the vitamin in the body with extremely 
satisfying results at minimum costs and adverse effects. 
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LITERATURE REVIEW 
 The concept of deficiency in vitamin B12 levels has been around in the Indian 
medical field for quite a long while. Renewed interest has however recently crept up 
again in this subject with the notion that this medical problem maybe more widespread 
and complicated than previously anticipated. Our knowledge about this subject is far 
from complete. 
 
Historical perspective 
 The origin of the literature on vitamin B12 probably began with the earliest 
observations and descriptions of key manifestations of its deficiency in the nature of 
pernicious anaemia and subacute combined degeneration of the spinal cord. 
 The earliest published report of an illness akin to the complete spectrum of 
vitamin B12 deficiency has been documented by James Combe of Edinburgh (1) – 
however there was no confirmatory evidence of either pernicious anaemia or subacute 
combined degeneration in his report. 
 Subsequently in 1849 Thomas Addison first described pernicious anaemia (2) as a 
distinct entity. This was initially named Addisonian anaemia by Trousseau. Later 
Addison and Fenwick described the coexistence of anaemia, debility and gastric atrophy 
as a clinical syndrome (3) which unlike the other known anaemias at that point of time 
was almost always fatal. 
 Down the line scholars like Biermer, Leichtenstein, Gowers, Lichtheim, Hunter 
and Russell all made significant contributions to provide parts of the entire clinical 
 13
spectrum (4). Paul Ehrlich first in 1880 coined the term “megaloblast” (4) to describe the 
large cells in the bone marrow observed in the spectrum of vitamin B12 deficiency. 
 Nevertheless, the first person to convincingly propose a link between subacute 
combined degeneration and pernicious anaemia was probably James J Putnam (5). In 
1890, he reported 8 “enfeebled patients” (7 ladies and 1 gentleman), with combined 
changes of the pyramidal tracts and the posterior columns along with evidence of 
neuropathy – these people in addition, also had anaemia and suffered from exhaustion. 
For a while this clinical entity it was known by the phrase “Putnam Dana syndrome”. 
Interest in this field has been brewing in Christian Medical College, Vellore for 
around three decades now where the likes of Dr. Mathan and Dr. Baker have published 
extensively on the subject. Needless to say that information on this subject has come a 
long way since then. 
 
Vegetarianism in India 
 Vegetarianism has been well known and commonly found in India since ancient 
times. It has probably in many ways got entangled with the socio-religious psyche of the 
people. A survey published in The Hindu (6) a few years ago claimed that 31% of Indians 
are pure vegetarians and another 9% are vegetarians who eat egg – in other words, 40% 
of the country does not consume meat or fish. The tendency towards vegetarianism 
apparently seems to be more in land-locked states like Rajasthan, Haryana, Punjab, Uttar 
Pradesh etc and less in the coastal states like Kerala, Andhra Pradesh, Tamil Nadu, West 
Bengal etc. People have also claimed that India houses more vegetarians than all 
 14
vegetarians put together all over the world. In view of the above, India becomes a nation 
likely to harbor vitamin B12 deficiency in profusion among the masses. 
 
Epidemiology 
 The epidemiology of vitamin B12 deficiency has been changing from its first days 
of description. Factors that have been contributing to that are the various definitions both 
clinical and biochemical that have been proposed to define this condition. The wide array 
of available methods to objectively look for the levels of this vitamin and the various 
different sub-clinical forms of deficiency of this vitamin make its epidemiology even 
more heterogeneous. 
 
World data 
 A worldwide prevalence for a condition such as this is probably difficult to come 
by – however discrete reports in various articles have quoted prevalence in various 
regions of the world. Review of such data reveals that the numbers differ in various age 
groups (7).  
In the United States of America, reports of the National Health and Nutrition 
Examination Surveys performed between the years 1999 and 2002 have shown that 
vitamin B12 deficiency (vitamin B12 level less than 200 pg/mL) affected less than 3% of 
people between 20 to 39 years of age, around 4% of those between 40 to 59 years of age 
and around 6% of those above the age of 60 years (8; 9). Borderline levels (vitamin B12 
between 200 and 300 pg/mL) were commoner in the same population – about 14-16% 
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amongst those aged 20to 59 years of age and more than 20% amongst those above 60 
years of age. 
In the United Kingdom, 1 in 20 people in the age group of 65 to 74 years of age 
and about 1 in 10 people above the age of 75 years had this condition (10; 11).  
In Mexico according to the Mexican National Nutrition Survey, performed in 
1999 the prevalence of deficiency and marginal levels, was around 40% of all children 
and adults (12).  
Talking about Africa, 70% of Kenyan children were found to be deficient (13). 
In 2003, Herrmann et al (14) studied 174 apparently healthy subjects (66 people 
who were vegetarians with milk products and egg consumption, 29 vegans, and 79 people 
who were non vegetarians) living in Germany and Netherlands. 52% of the vegans had 
absolute deficiency of vitamin B12 and around 90% had indirect metabolic features 
suggestive of vitamin B12 deficiency (like elevated methylmalonic acid and 
homocysteine). 26% of the people who were vegetarians with milk products and egg 
consumption were deficient in vitamin B12 and only 1% of the non vegetarians were 
deficient in vitamin B12. 
 
Indian data 
 Community level data is not very forthcoming in the literature. However there is 
some data from India about community prevalence. In Pune, Maharashtra, India, Yajnik 
et al performed a study (15), where they randomly selected people within the age groups 
of 30 and 50 years from 2 villages, 2 slums and 2 middle class regions around Pune. They 
studied 441 subjects in all and the overall pooled prevalence of vitamin B12 deficiency 
 16
was 67%. Vegetarians had a three fold higher risk of having vitamin B12 deficiency as 
non vegetarians. 
A study by Jathar et al (16) in 1975 amongst healthy medical students had shown 
vitamin B12 deficiency to be prevalent in 47% of people taking a pure vegetarian diet 
along with milk products. 
In 1985 Chanarin et al published a study (17) where they studied 138 Indian 
patients with megaloblastic haemopoiesis. Among them there were 95 people (68%) who 
were deficient in vitamin B12. All the 138 patients were vegetarians. 20 of the vitamin 
B12 deficient people had pernicious anaemia. 
In 2001, Refsum et al (18) studied 204 men and women in Maharashtra, India for 
vitamin B12 deficiency. Of them 47% were found to have deficient vitamin B12. What is 
interesting is that in the same study the investigators went on to study the indirect 
metabolic indicators of vitamin B12 deficiency like raised homocysteine levels and raised 
methylmalonic acid levels and found “Functional vitamin B12 deficiency” in 77% of the 
subjects. This study tells us two things – firstly in any study where we are assessing the 
prevalence of vitamin B12 deficiency with absolute vitamin B12 levels, there is bound to 
be underestimation of its prevalence, and secondly the clinical spectrum of vitamin B12 
deficiency possibly begins long before the actual fall in the levels to the point of absolute 
deficiency. 
Previously unpublished data from our centre that had looked at an elderly 
population of patients (200 patients with age greater than 60 years) with frank dementia 
found that 38 patients (19%) had vitamin B12 deficiency. 
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In a pilot study, done as a prelude to this study, in our own hospital, among fifty 
new vegetarian outpatients, 22 (44%) were found to be deficient in vitamin B12 levels. 
While doing this analysis there were quite a few people who were non vegetarians but 
were still found to have low vitamin B12 levels – hence there is probably a sizeable 
population amongst non vegetarians as well that will probably be deficient in this vitamin 
that requires investigating at a later stage. 
Apart from this there is a great dearth of any further data on the prevalence (be it 
community based or hospital based), of vitamin B12 deficiency in the country. The 
quoted percentages seem to be distinctly higher than any other such value from anywhere 
else in the world. Is it representative of the entire country? We would probably need to 
anticipate for more data in this area before any definitive conclusions can be drawn 
regarding this issue. 
 
Etiology of vitamin B12 deficiency 
 Traditional causes of vitamin B12 deficiency are well known and well studied. 
However newer factors attributing to this deficiency are being proposed by the day. The 
following table (refer table 1) is an attempt to summarize the well addressed causes under 
one heading. 
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Table 1: Etiology of vitamin B12 deficiency 
Pernicious anaemia 
   Autoantibody formation 
   Chronic atrophic gastritis 
   Helicobacter pylori 
Cobalamine malabsorption 
   Gastric atrophy, achlorhydria 
   Helicobacter pylori infection 
   Intestinal bacterial overgrowth secondary to antibiotic treatment 
   Long-term ingestion of biguanides, antacids, H2 receptor antagonists, and proton pump 
inhibitors 
   Chronic alcoholism 
   Gastric surgery/reconstruction for obesity (bariatric surgery) 
   Pancreatic exocrine failure 
   Sjogren's syndrome 
   Ileal disease (including tuberculous ileitis, lymphoma, amyloid, long-term survivors of 
pelvic irradiation), resection or bypass, and Crohn's disease 
   Zollinger Ellison syndrome 
   Gluten induced enteropathy 
Infections 
   Diphyllobothrium latum 
   Human immunodeficiency virus 
Hereditary conditions 
   Qualitative abnormalities of intrinsic factor 
   Imerslund-Grasbeck's disease or juvenile megaloblastic anaemia 
   Congenital deficiency of transcobalamin 
   Homocystinuria 
   Severe methylenetetrahydrofolate reductase deficiency 
   Abnormalities of methionine synthesis 
   Abnormal lysosomal membrane exporter for cobalamin 
Nitrous oxide exposure 
Radiotherapy 
Graft versus host disease 
Poor dietary intake 
 
Risk factors for vitamin B12 deficiency amongst vegetarians 
 The reason for low levels in vitamin B12 deficient vegetarians is most likely due 
to an absence of vitamin B12 in a pure vegetarian diet. But is that the whole truth? Could 
there be other associated or superadded factors that contribute to it? The fact that not all 
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vegetarians are deficient, added to the fact that even non vegetarians suffer from severe 
deficiency, lets one to the belief that there must be other factors involved in this process 
rather than diet solely. 
 
Water 
There is a study by Mathan et al (19), done long back, which demonstrated that 
small quantities of vitamin B12 are present in drinking water probably due to faecal 
contamination of the water. Hence the possibility remains that a part of the population 
derives its share of vitamin B12 actually from the water itself. If we consider that, in the 
entire community there has been a general trend towards shifting towards more and more 
purified sources of drinking water, then it is possible to consider that people using more 
purified sources of water, are at a higher risk of acquiring this deficiency compared to 
people who use less pure forms of drinking water. This would be a hypothesis by itself as 
there is not much literature to go by in this field apart from Dr. Mathan’s study (19). This 
is one factor that we looked at in our current study to check if the nature of the drinking 
water had any bearing on the prevalence of vitamin B12 deficiency. 
 
Pernicious anaemia 
Pernicious anaemia is known to be a cause of vitamin B12 deficiency (20). The 
possibility remains, in this situation, of Occam’s razor being blunted and coexistence of 
pernicious anaemia along with vegetarianism leading to vitamin B12 deficiency. Is there 
any coexistence of the two in an Indian population – no one really knows. In the study by 
Jathar et al (16), Schilling tests were carried out on his group of medical students and 
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there was enough evidence to say at least that the intestinal absorption of vitamin B12 is 
similar amongst the vegetarians and the non vegetarians. However as to the exact 
question of whether there is coexisting pernicious anaemia, there is no answer. In an 
attempt to address this point we tried to look for any evidence of the possibility of the co-
occurrence of pernicious anaemia in this group of people. 
The diagnosis of pernicious anaemia is made by a combination of macrocytic 
anaemia, documented vitamin B12 deficiency, demonstration of atrophic body gastritis, 
and intrinsic factor deficiency (20). However indirect evidence of such a disorder may be 
obtained with the help of intrinsic factor antibodies and parietal cell antibodies. How 
good would they be in predicting this condition? This issue has been assessed recently 
and it has been found that intrinsic factor antibodies have a sensitivity and a specificity of 
37% and 100% respectively while anti parietal cell antibodies have a sensitivity and 
specificity of 81.5% and 93.3% respectively (21). In our study we used these antibodies 
as possible surrogate markers for pernicious anaemia. Our study was limited by the lack 
of funds to do the entire evaluation required for the patients in order to prove a diagnosis 
of pernicious anaemia conclusively. 
 
Drugs 
 Usage of certain drugs has been in the past studied in association with vitamin 
B12 deficiency. In one study, 53 vitamin B12 deficient patients were compared with 212 
controls, all above the age group of 65 years for past or current use of either of H2 
receptor antagonists or proton pump inhibitors according to review of the patient’s 
medical records (22). Once factors like age, gender, multivitamin use and Helicobacter 
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pylori infection were controlled for, chronic or current use of the above drugs were 
significantly associated with an increased risk of vitamin B12 deficiency (odds ratio 1.47-
13.34). In another report (23) that looked at a cross-section of elderly people with respect 
to the use of acid suppression and vitamin B12 deficiency, it was found that proton pump 
inhibitors but no H2 receptor blockers were statistically associated with the risk of 
vitamin B12 deficiency. We also looked at whether significant acid suppression existed 
within our study population and whether that in any way related to vitamin B12 
deficiency. 
 There is data now at the level of a randomized trial to suggest that metformin use 
is a risk factor for developing vitamin B12 deficiency. In this multi centre randomized 
placebo controlled trial (24), 390 patients with type 2 diabetes mellitus on insulin, were 
randomized into metformin (850mg three times a day) and placebo. The main outcome 
measure was the percentage change in vitamin B12 levels at various intervals till 52 
months of follow up. Compared with placebo, treatment with metformin was associated 
with a statistically significant mean decrease in vitamin B12 levels of 19%. This trial was 
published in 2010 and actually when we started our study this trial had not been 
published. Hence we also looked at whether metformin was significantly associated with 
vitamin B12 deficiency. 
 
Others 
The other possibility is to consider whether there could be some inhibitors in a 
vegetarian diet that would lead to inadequate absorption of the vitamin. Now this is 
absolutely new ground here where there is no data at all whatsoever about this possibility. 
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Indians are known to chew pan and betel leaves and the like and these practices are 
common in the vegetarian population. Hence we conjured that it may be worth studying 
if pan, betel leaves and other such agents have any association with vitamin B12 
deficiency. 
 
Absorption and handling of vitamin B12 
 Dietary cobalamin after ingestion reaches the stomach and in the presence of acid 
and pepsin in the stomach is liberated from binding to protein and then quickly binds to R 
factors (cobalamin-binding proteins) in saliva and gastric juice. Cobalamin bound to R 
factors is not absorbed; however, in the alkaline pancreatic enzyme environment of the 
duodenum, cobalamin is freed from R proteins by pancreatic proteases and then binds 
specifically and rapidly to gastric-derived intrinsic factor. Intrinsic factor is a 45 kilo 
Dalton glycoprotein with very high affinity for cobalamin. 
The intrinsic factor - cobalamin complex binds to a specific ileal receptor, cubilin, 
from which it is absorbed via an energy requiring process that is still not completely 
understood (25-27). Electron microscopic studies have shown colocalization of cubilin 
with the endocytic proteins megalin and "amnionless" (AMN), which may mediate 
vesicular trafficking of the complex, via a calcium-dependent mechanism (28). It is 
possible that the functional ileal receptor for the cobalamin-intrinsic factor complex is a 
complex of AMN and cubulin (29). 
Mutations in either the cubilin gene or the AMN gene can cause hereditary 
megaloblastic anemia, while absence of megalin has been associated with failure of 
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normal renal tubular reabsorption of the Cobalamin-transcobalamin complex in mice 
(30). 
Thus, adequate absorption of cobalamin depends upon five factors: 
     * Adequate dietary intake 
     * Acid-pepsin in the stomach 
     * Pancreatic proteases 
     * Gastric secretion of a functional intrinsic factor 
     * An ileum with functioning cobalamin-intrinsic factor receptors 
The need for an intact upper gastrointestinal tract for effective absorption of 
cobalamin and folic acid has been shown in a report of patients receiving a Roux-en-Y 
gastric bypass for morbid obesity. Standard multivitamin preparations were inadequate to 
maintain vitamin B12, folic acid, iron, calcium, and vitamin D levels (31). 
After being taken up by ileal enterocytes, cobalamin is exported via the ATP-
binding cassette (ABC)-drug transporter ABCC1 (also called multidrug resistance 
protein, MRP1), present in the basolateral membrane of intestinal epithelium and other 
cells (32). Cobalamin enters plasma, bound to three transcobalamins: transcobalamin I, 
II, and III. Up to 80 percent of cobalamin is bound to transcobalamin I and III, which 
have no identified role in cobalamin metabolism (33). It is the transcobalamin II- 
cobalamin complex that is physiologically important. The three-dimensional structure of 
transcobalamin shows that there are 2 domains for binding cobalamin (29). This complex 
has a half-life of six to nine minutes and binds to specific cell surface receptors from 
which it enters cells by receptor mediated endocytosis. Cobalamin in the cells is 
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metabolized into two coenzymes: adenosyl-cobalamin; and methyl-cobalamin, the 
functions of which are described below (33). 
 
Figure 1: Handling of vitamin B12 (34) 
 
Physiological role of vitamin B12 
 The concerted action of these two vitamins leads to the DNA synthesis required in 
cells undergoing rapid turnover, such as hematopoietic and enteric lining cells. Although 
the exact steps remain elusive, cobalamin has two known cofactor actions as shown 
below (refer figure 2). 
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Figure 2: Physiological role of cobalamin and folate (33) 
 
Conversion of propionyl-CoA to methylmalonyl CoA and finally to succinyl-CoA 
— the biologic significance of this sequence remains unknown. There is no interaction 
with folic acid in this pathway; as a result, it has been proposed that this pathway might 
be important in myelin formation and in the neurological abnormalities typical with 
vitamin B12 but not folic acid deficiency (33). However, the observation that hereditary 
deficiencies of the enzyme methylmalonyl CoA mutase do not cause neuropathy is not 
consistent with this hypothesis. 
Transfer of a methyl group from methyl-tetrahydrofolate (methyl-THF) via 
cobalamin to homocysteine to form methionine — this reaction has two important 
effects: it reduces the plasma concentration of homocysteine, which is probably toxic to 
endothelial cells; and, perhaps more importantly, it demethylates THF. Demethylation is 
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a critical step in DNA synthesis because THF (the reduced form of folate) and not 
methyl-THF is the substrate for the enzyme that converts (THF)-1 to the polyglutamated 
form, (THF)n. 
Only polyglutamated (THF)n participates in purine synthesis and in converting 
deoxyuridylate to thymidylate via the transfer of 1-carbon units (33). As an example, 
methylene-(THF)n transfers a methylene molecule to convert deoxyuridylate to 
thymidylate. Methylene (THF)n can also be oxidized to formyl (THF)n, which is 
important in purine synthesis. 
 
Figure 3: Role of cobalamin (33) 
Effects of cobalamin and folic acid deficiency 
There are three main consequences: 
    * Increased homocysteine levels 
    * Reduced methionine levels 
    * Impaired formation of THF 
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Two observations suggest that methionine deficiency may play a major role in the 
neuropathy associated with cobalamin deficiency. First, neuropathy can be produced by 
toxic exposure to the gas nitric oxide (NO), which inhibits methionine synthase. Second, 
methionine administration has been beneficial in an animal model of cobalamin 
neuropathy (35). The mechanism by which methionine deficiency causes neuropathy and 
why neuropathy does not occur with folate deficiency remain unclear. 
In addition, adult cobalamin-deficient patients have high levels of TNF-alpha and 
low levels of EGF in the serum and cerebrospinal fluid; these levels normalize along with 
hematologic disease remission following treatment. Hence these molecules might also be 
involved in the pathophysiology of this process. 
 
Pathophysiology of megaloblastosis 
Deficiency of cobalamin and folic acid leads to megaloblastic erythropoiesis and 
frequently to disordered maturation in the granulocytic and megakaryocytic lineages. The 
ultimate basis for the megaloblast is inadequate conversion of deoxyuridylate to 
thymidylate, which leads to slowing of DNA synthesis and delayed nuclear maturation. 
RNA and protein synthesis proceed normally, resulting in the characteristic "cytonuclear" 
dissociation of the megaloblast. 
There are two hypotheses concerning the exact mechanism by which these 
vitamin deficiencies slow DNA synthesis (figure 3): 
    * In cobalamin deficiency, methyl-THF cannot be demethylated; as a result, there is no 
THF available for the critical polyglutamation step discussed above. This is the 
"methylfolate trap" hypothesis, which can theoretically explain many of the metabolic 
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abnormalities identified (33). However, demethylated-THF does not correct these 
abnormalities, raising a question about the validity of this hypothesis (33). 
    * An alternative explanation, the "formate starvation hypothesis", proposes that 
methionine deficiency is the primary problem. Support for this hypothesis comes from 
the partial correction of many of the metabolic abnormalities with methionine and from 
the observation that methionine functions to enhance generation of formyl-(THF)n either 
directly or when converted to S-adenosyl methionine (figure 3) (33). 
 
Ineffective erythropoiesis 
Regardless of the mechanism, the morphologic hallmark of cobalamin and folate 
deficiency is megaloblastic erythropoiesis, which probably reflects the defective DNA 
synthesis. The kinetic and morphologic cause of the anaemia is ineffective erythropoiesis 
or intramedullary hemolysis. This means that there is intense erythroid hyperplasia in the 
marrow but relative reticulocytopenia. Thus, the erythroid precursors are not maturing 
normally and are dying in the bone marrow, resulting in the lack of orderly delivery of 
red cells into the peripheral blood. 
 
Figure 4: Hypersegmented neutrophil 
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Figure 5: Megaloblastic eryhthropoesis 
The underlying mechanism of ineffective erythropoiesis, as tested in an animal 
model of folate deficiency, is enhanced apoptosis (36). The apoptosis is prevented in this 
model by thymidine administration, thereby emphasizing the importance of the block in 
the synthesis of thymidylate (36). However, in patients with megaloblastic erythropoiesis 
due to cobalamin or folate deficiency, intramedullary death of RBC precursors is not 
characterized by apoptosis (37; 38), and requires a different explanation. 
 
Ineffective megakaryocytopoiesis — The same defect presumably occurs in 
myeloid and megakaryocytic precursors. In severe cobalamin deficiency, the low platelet 
count is associated with a marked increase in the number of megakaryocytes but 
diminished ploidy, resulting in an expanded megakaryocyte mass but reduced platelet 
production per megakaryocyte. 
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Manifestations of vitamin B12 deficiency 
 Physical characteristics of vitamin B12 deficiency could be markedly varied. 
Sometimes the features could be remarkably subtle (34) – so subtle in fact as to merit 
being labeled asymptomatic. They two most prominent and potentially serious 
presentations are haematological and neuropsychiatric. Newer hypotheses about end 
organ damage are being considered in the literature every day. 
 
Mucocutaneous manifestations 
 Mucocutaneous changes may be picked up on careful examination in people with 
vitamin B12 deficiency. Some of them may not be very specific. But they may be clues to 
the possible underlying diagnosis of cobalamin deficiency. 
 The pigmentation of vitamin B12 deficiency is generally markedly pronounced in 
the hands and the feet and especially in the creases of the palmar and the plantar aspects. 
Sometimes hyperpigmentation has been seen to be accentuated over the terminal 
phalanges and over the pressure points such as the elbows, malleoli and the knees. Rarely 
excess pigmentation has also been noticed in the buccal mucosal membrane with spotty 
pigmentation of the tongue (39). Nails can show longitudinal hyperpigmented streaks, but 
the nail beds may actually be pale. One paradoxical finding in terms of pigmentation 
maybe early graying; this has also been described (39). 
 The mechanism of hyperpigmentation may be most likely associated with 
alterations with tyrosine levels (40). A deficiency of vitamin B12 causes a decrease in 
reduced glutathione levels, and tyrosinase, an enzyme necessary for melanogenesis, is 
inhibited by reduced glutathione. Therefore the decrease in reduced glutathione levels in 
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vitamin B12 deficiency leads to an increase in tyrosinase levels, giving rise to 
hypermelanosis. 
 Changes in the oral mucosa in vitamin B12 deficiency maybe important as many 
of these features predate the systemic manifestations of this condition (41). A wide range 
of oral signs and symptoms may appear in such patients as a result of basic changes in the 
metabolism of oral epithelial cells. These changes give rise to abnormalities in cell 
structure and the keratinization pattern of the oral epithelium leading to a “beefy” red and 
inflamed tongue with erythematous macular lesions on the dorsal and border surfaces 
because of marked epithelial atrophy and reduced thickness of the epithelial layer (42). 
 
Haematological manifestations 
 
Macrocytic anaemia 
 Macrocytosis has been defined as a mean corpuscular volume greater than 100fl 
(43). Apparently it can be found in about 3% of the normal population (43). Macrocytosis 
can be due to a host of causes, B12 deficiency being just one amongst them. 
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 Causes of macrocytosis: (43) 
 
Table 2: Etiology of macrocytosis 
 
Evaluation of macrocytosis can be done based on the following algorithm: (43) 
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Figure 6: Algorithm for evaluation of macrocytosis 
 
Vitamin B12 deficiency is a well known cause of macrocytic anaemia with 
evidence of haemolysis. It is possible for it to present even as frank pancytopenia (44). 
Strangely enough the haematological abnormalities may not be seen in all patients with 
deficient vitamin B12 levels. In Dr. Yajnik’s study, though 67% of the subjects had low 
vitamin B12 concentration, only 2% had an elevated mean corpuscular volume (15). This 
could be due to the fact that there may have been coexisting iron deficiency also in the 
population. Andres et al (45) studied the haematological manifestations of 201 vitamin 
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B12 deficient people and found that anaemia was present in 37% of the subjects and 
macrocytosis in 54%. In the pilot study done in our hospital only 4 of the fifty patients 
looked at, had a mean corpuscular volume of 90 and above (8%), and 13 of the fifty 
(26%) had anaemia. Hence from the above reports it looks as though vitamin B12 
deficiency can present in subtle ways with no change in the mean corpuscular volume or 
the blood picture. This basically goes on to indicate that the profiles of these 
haematological manifestations are not very clearly defined – nor do they seem to be 
uniform. Hence the threshold for suspecting vitamin B12 deficiency may be actually 
quite low and probably a normal mean corpuscular volume in the blood work might not 
rule out vitamin B12 deficiency. We therefore, looked at the possibility of whether there 
could be a value for the mean corpuscular volume that could actually predict vitamin B12 
deficiency with a reasonable degree of certainty in our study population. 
 
Vascular thrombosis 
 We know that vitamin B12 deficiency is accompanied by hyperhomocysteinemia 
and elevated methyl malonic acid levels in the serum. The serum levels of homocysteine 
and methyl malonic acid actually rise earlier than the actual dip of vitamin B12 values to 
absolute deficient levels – some people have termed this as “Functional vitamin B12 
deficiency” (18). Hyperhomocysteinemia has been implicated as a risk factor for 
thrombotic disease (46). There are a handful scattered reports in the literature where 
vitamin B12 was evidently causatively associated with thrombosis (47). This raises the 
issue of whether regular screening for vitamin B12 levels would be necessary for 
evaluating any patient with an unprovoked thrombosis with no other vascular risk factors. 
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In this context it would be interesting to study whether such manifestations are evident in 
our population. 
 
Other haematological manifestations 
 Apart from macrocytosis, other unusual haematological manifestations that have 
been described in the literature are severe pancytopenia, splenomegaly, mild icterus and 
leucoerythroblastosis (48). There can be circulating immature sells as well on the 
peripheral blood smear (48). These findings having been described in the past – however 
in the recent past they have not really been prominently portrayed. These maybe markers 
of severe megaloblastic erythropoesis and must be kept in mind when looking for 
haematological abnormalities associated with this condition. 
 
Neuropsychiatric manifestations 
Neuropsychiatric and neurological manifestations of vitamin B12 deficiency are 
well known but are varied and with time newer features and associations are being 
described (49; 50). 
 
Neurological syndromes 
Amongst the common neurological manifestations is peripheral neuropathy that 
has been well documented (51). Dorsal myelopathy in the form of the typical sub acute 
combined degeneration is also well studied (52). In subacute combined degeneration 
there is generally an involvement of both the posterior columns (dorsal columns) as well 
as the lateral cords (pyramidal system). These lesions specific for vitamin B12 deficiency 
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are due to a defect in myelin formation of unknown mechanisms. The neuropathy is 
symmetrical and affects the legs more than the arms. It begins with paraesthesias and 
ataxia associated with loss of vibration and position sense, and can progress to severe 
weakness, spasticity, clonus, paraplegia, and even fecal and urinary incontinence (53). 
Optic neuropathy though very rare also has been described in cobalamin deficiency as a 
cause of painless progressive loss of vision (54). Most of the neurological manifestations 
if picked up fairly early in the disease can be reversible with adequate and appropriate 
supplementation. 
 
Dementia 
There are only a few reversible causes of dementia in the elderly of which 
Vitamin B12 deficiency is the most easily treatable one. Vitamin B12 deficiency can 
cause isolated dementia or can be a coexisting factor in other irreversible dementias. 
The first major study which looked into various causes of dementia in elderly 
(>60yrs) in India was from SGPGI hospital (55). It was a prospective study conducted on 
124 (94 male and 30 female) elderly patients (aged more than 60 years) presenting with 
clinical syndrome of dementia (MMSE less than 24). Their age range was 64-78 (mean 
65.7 4.1) years. Multi-infarct dementia (MID) was observed to be commonest cause of 
dementia and was present in 59 (47.6%) cases followed by,10 (8%) patients each of 
tuberculosis (TB) and neurocysticercosis (NCC), Alcohol-related dementia in 13 
(10.5%),malnutrition (Vitamin B12 deficiency) was present in 9 (7.2%), Alzheimer’s 
disease (AD) in 6 patients (4.8%),1 each of Huntington's disease, Parkinson's and Normal 
Pressure Hydrocephalus and 2 each of diabetes, hypothyroidism, hyperthyroidism and 
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Creutzfeldt' Jakob Disease. It was concluded that AD, which is irreversible and common 
in the west, is relatively uncommon in India as compared to M.I.D, infections and 
malnutrition, which are potentially treatable. In its classic form dementia associated with 
B12 deficiency presents as subcortical dementia. 
 
Psychiatric syndromes 
In our experience in the out patient department of our hospital we had been seeing 
a number of patients with B12 deficiency presenting with multiple somatic complaints 
(bordering on anxiety/depression spectrum). So we wondered whether there were other as 
to date not well studied neuropsychiatric rather than pure neurological features of this 
condition. 
Strangely enough a review of the literature revealed that psychiatric symptoms 
attributable to vitamin B12 deficiency had been described for decades. These symptoms 
seem to fall into several clinically separate categories: slow cerebration, confusion, 
memory changes, delirium with or without hallucinations and or delusions, depression, 
acute psychotic states, and more rarely, reversible manic and schizophreniform states 
(56). A higher prevalence of low serum vitamin B12 levels have been found in subjects 
with Alzheimer’s disease and other dementias and in people with different cognitive 
impairments, as compared with controls (57). Furthermore, some interventional studies 
have shown the effectiveness of vitamin B12 supplementation in improving cognition in 
demented or cognitively impaired subjects. Martin D C et al reported a study in 1992, 
where twenty-two subjects with low serum vitamin B12 levels and evidence of cognitive 
dysfunction, were recruited consecutively over an 8-month period of time. Subjects 
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received 1000 micrograms of cyanocobalamin intramuscularly daily for 1 week, then 
weekly for 1 month, then monthly thereafter for a minimum of six months. Patients 
symptomatic for less than 12 months gained an average of twenty points on the Mattis 
Dementia Rating Scale (paired t test P = 0.0076), whereas patients symptomatic greater 
than 12 months lost an average of three points (paired t test P = .34) (58), indicating 
benefit with early replacement therapy. 
Dementia is increasingly being picked up in the population. To quote an example, 
a three year epidemiological survey (59) was carried out in an urban community setting 
in Mumbai, India, where the prevalence of dementia was determined. The prevalence rate 
for dementia in those aged 40 years and more was 0.43%, and for persons aged 65 and 
above was 2.44%. The most common cause of dementia identified in this particular study 
was Alzheimer’s disease followed by vascular dementia being the second most common 
cause. 
In one series (60) where the investigators had studied 129 consecutive patients 
presenting to a hospital and fulfilling criteria for dementia, 24 patients had reversible 
causes of dementia of which only 5 patients had vitamin B12 deficiency. In previously 
unpublished data from our very own hospital, where 200 patients in the age group more 
than 60 years of age, with DSM IV criteria proven dementia were studied, it was found 
that around 10 % of the patients had dementia solely due to vitamin B12 deficiency and 
the overall incidence of vitamin B12 deficiency was around 19%. 
Hence there is a need to actively look out for these uncommon neuropsychiatric 
and neurological manifestations for their further characterization. This is necessary in 
order to lower the threshold for the detection of vitamin B12 deficiency. Systematic data 
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regarding the prevalence of anxiety and depression amongst the b12 deficient is not really 
available in the literature. 
 
Treatment of vitamin B12 deficiency 
 Parenteral cobalamin — Pernicious anemia is typically treated with parenteral 
(i.e., intramuscular or deep subcutaneous) cobalamin, in a dose of 1000 micrograms 
(1000 mcg, 1 mg) every day for one week, followed by 1 mg every week for four weeks 
and then, if the underlying disorder persists (e.g., pernicious anaemia, surgical removal of 
the terminal ileum), 1 mg every month for the remainder of the patient's life. If the cause 
of the cobalamin deficiency can be eliminated (e.g., diet, drugs, reversible malabsorption 
syndromes), treatment can be stopped when the cobalamin deficiency has been fully 
reversed and the cause eliminated. 
While doses lower than those noted above have been recommended (i.e., 100 
micrograms in place of 1,000 micrograms), there are few adverse consequences of this 
potential "overtreatment", as parenteral vitamin B12 is inexpensive, fairly nontoxic, and 
amounts given in excess of need are excreted harmlessly in the urine. Conversely, use of 
the lower dose could result in a slower response, which might be critically 
disadvantageous when severe neurological disease (e.g., subacute combined 
degeneration) is present and avoidance of irreversible neurological damage is a concern 
(52). 
Oral and nasal formulations — An alternative that appears to be as effective as 
parenteral therapy, but which requires much greater patient compliance, is high dose oral 
cobalamin. The rationale for this approach in patients with impaired intrinsic factor 
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function is the presence of a second, lower efficiency transport system for cobalamin that 
does not require intrinsic factor or a functioning terminal ileum. This system consistently 
produces adequate long-term vitamin B12 replacement at doses of 1000 to 2000 mcg/day. 
Because of variability in absorption, lower oral doses are not completely effective in 
some patients with pernicious anemia (61).  
The dose given in this situation (1 to 2 milligrams/day) is more than 200 times 
higher than the minimum daily requirement for normal subjects (62), and significantly 
higher than that available in most standard multivitamins and B12 supplements (≤100 
mcg/day) (63). 
In the few randomized clinical trials which have been reported, the use of oral 
cobalamin (1000 to 2000 mcg/day) in newly diagnosed patients was found to be as 
effective as intramuscular administration in obtaining short-term haematological and 
neurological responses in vitamin B12-deficient patients (64-66). 
Because of the possibility of erratic absorption, it is most appropriate to use this 
route of treatment after the patient's cobalamin status has been normalized with parenteral 
treatment and/or to monitor the response frequently with determinations of serum 
cobalamin and methylmalonate concentrations. 
Cobalamin can also be given sublingually (67), or via a nasal spray or gel (68). 
Sublingual and nasal routes of treatment have not been adequately studied and the 
available formulations are expensive (69). 
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Awareness regarding vitamin B12 deficiency 
Often we see in the outpatient department that vegetarians are not aware of this 
condition of vitamin B12 deficiency. Vegetarians especially maybe a subset of the 
population who may benefit from education on this front. A lot of them may not actually 
be on supplementation. There is absolutely no data about the awareness of this condition 
in the Indian population. Sometimes there maybe a dearth of awareness of this even 
among various sections of the medical community. Unless it is shown consistently in 
Indian studies that this is a potential problem, the awareness may continue to be low. 
Hence an assessment of the level of knowledge amongst the subjects themselves maybe 
of the essence to take the first step towards making this an important public health 
problem. 
So it would seem to suggest that though the problem of Vitamin B12 surfaced in 
the early 1970s there have been only very few studies substantiating the prevalence of the 
disease, making this a relevant point of further studies. Also the indirect evidence that can 
be possibly gathered from all the above mentioned studies would indicate that the 
prevalence of the problem may actually be quite high.  
The clues to vitamin B12 deficiency in the out patient department though 
occasionally glaringly simple might in many situations be more subtle and easily missed - 
looking at the prevalence of anaemia in vitamin B12 deficient people. This further drives 
home the point that among the varied spectrum of manifestations of vitamin B12 
deficiency there maybe no evidence of anaemia, with other features being present, even 
with very low levels of vitamin B12. This group would include a lot of fairly 
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asymptomatic individuals with low vitamin B12 levels – the exact clinical correlates of 
such a situation remain to be clearly elucidated. 
In this study we will try to look at the prevalence of vitamin B12 deficiency 
among new vegetarian patients visiting the internal medicine out patient department of 
the Christian Medical College and Hospital, Vellore. We will also look at the clinical 
profile of the patients and try to identify possible uncommon neuropsychiatric 
manifestations of this condition like anxiety and depression. We will also study if there 
are any significant differences between deficient subjects and normal subjects with 
respect to exposure factors like the nature of the drinking water, the use of betel leaves 
and jarda, the use of proton pump inhibitors / H2 receptor blockers, and the use of aspirin 
or metformin. We will also try to look at the awareness of the vegetarians regarding this 
condition. 
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MATERIALS AND METHODS 
Study design 
 This study was carried out based on the principles of a cross sectional study 
design. It involved observation and obtaining scientific readings at a particular point in 
time, with no follow up, either prospectively or retrospectively. A cross sectional study is 
amenable for the analysis of prevalence data and that being our primary objective, this 
particular study design was chosen. 
 
Study population 
 A prevalence study for any factor is best done in the community – in a lot of 
situations that would reduce the bias of a hospital study. This being a hospital study has 
its own limitations. However as far as possible we wanted to choose a population in our 
hospital survey that would most closely reflect the community or the general population 
at large. Hence for our study, we excluded people who were significantly ill or people 
with multiple interacting problems. We also excluded the elderly as in that population 
there would be the elements of age, poor absorption and poor nutrition confounding the 
results. Thus we ended up with the following: 
 Inclusion criteria: 
1. Vegetarian patients coming to the out patient department of the Internal 
Medicine Department of Christian Medical College, Vellore, India. 
2. Consenting males and females between 18 and 60 years of age. 
3. First visit to Christian Medical College, Vellore. 
4. Ambulant patient. 
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Vegetarian patients were defined as patients that had been consuming a diet devoid of 
any form of meat, at least for three completed years prior to the date of recruitment. 
Exclusion criteria: 
1. Patients on supplementation with vitamin B12 either orally or parenterally. 
2. Patients with overt features of malabsorption. 
3. Patients with chronic diarrhoea. 
4. Patients with severe hepatic, renal, pulmonary, cardiac or neurological 
disease. 
5. Patients with advanced malignancy. 
6. Patients with dementia. 
 
Study setting 
 This study was conducted in the out patient department of the Department of 
Internal Medicine, in Christian Medical College and Hospital, Vellore, which is a tertiary 
care teaching and research hospital, situated in Tamil Nadu, in South India. The 
biochemical analysis of the results was done in the Department of Clinical Biochemistry, 
in Christian Medical College and Hospital, Vellore, while the haematological parameters 
were measured at the Department of Clinical Pathology, in Christian Medical College 
and Hospital, Vellore. 
 
Subject enrollment 
 Eligible patients, after fulfilling the inclusion and exclusion criteria, were 
informed about the nature of the study and their specific role in it and were recruited at 
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the time of first presentation to the out patient department, in the Department of Internal 
Medicine. Informed consent was taken, with the help of a form (see Annexure 1, 
“Informed Consent”). 
 
Methodology 
 A history and physical examination was done for all patients at the time of the 
first contact and enrollment. Detailed collection of data was performed for all the subjects 
in the following areas: 
1. Epidemiological and geographic profile 
2. Demographic profile and the reason for attending the outpatient clinic 
3. Dietary profiles, that were sub divided into three groups 
4. Clinical profile including specific symptoms and signs: 
 a. Pallor 
b. Jaundice 
c. Hyperpigmentation 
d. Glossitis 
e. Sub acute combined degeneration 
f. Presence of paraesthesias 
5. Comorbidity profile: 
a. Diabetes mellitus 
b. Hypertension 
c. Ischemic heart disease 
d. Cerebrovascular disease 
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6. Specific risk factors assessment – nature of drinking water, toxins, drugs exposure 
7. Awareness profile – regarding this condition 
8. Neuropsychiatric profile – in terms of anxiety and depression scores 
9. Laboratory investigations: 
 a. Haemoglobin (by automated coulter counter) 
 b. Mean corpuscular volume (by automated coulter counter) 
 c. Serum vitamin B12 level (by chemiluminiscence assay) 
 d. Serum folate level (by chemiluminiscence assay) 
 e. Pernicious anaemia antibody screen 
Data regarding the epidemiologic profile, the dietary profile, the clinical profile 
and the level of awareness were recorded in a preformed proforma (see Annexure 2, 
“Raw data collection sheet”). The proforma was filled in by the investigator at the time of 
the first interview and contact. 
The neuropsychiatric profile of the subjects was assessed by two investigator 
administered questionnaires: 
[1] Hospital Anxiety and Depression Score – This has been validated (70-73) 
before in various situations (Annexure 3). 
[2] General Health Questionnaire – 12 (Annexure 4); this has also been validated 
before (74; 72). 
Both the above two questionnaires could have been used as self administered 
forms, but for the sake of standardization, they were administered by the investigator who 
was constant for the entire population of study. 
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At the point of contact with the subject in the outpatient department he or she also 
underwent certain biochemical and haematological tests that included serum vitamin B12 
and folate levels, and basic haemograms. For a subset of the subjects, serum pernicious 
anaemia antibody screens were also ordered for – they included the intrinsic factor 
antibody and the parietal cell antibody. 
 
Sample size calculation 
 This study was a cross sectional prevalence study and hence the following 
expression was used to calculate the sample size. 
n= z2 p (1-p) 
 d 
Where n = sample size, z = z statistic for a level of confidence, p = expected prevalence 
or proportion and d = precision. 
According to existing data from the study by Yajnik et al (15) the prevalence of 
vitamin B12 deficiency was taken to be 60% and the precision was taken as 10%. With 
the above figures a sample size of 94 was arrived at. The aim of the study was to get a 
total of 100 people as the sample population. In total at the end of the study a total of 108 
subjects were recruited and their results were analysed. 
 
Biochemical estimation of vitamin B12 
 Vitamin B12 in the serum samples was measured by an Elecsys 2010 Vitamin 
B12 assay (MODULAR ANALYTICS 2010). The Elecsys vitamin B12 assay employs a 
competitive test principle using intrinsic factor specific for vitamin B12. Vitamin B12 in 
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the sample competes with the added vitamin B12 labelled with biotin for the binding sites 
on the ruthenium-labelled intrinsic factor complex. 
 
Data integration and analysis 
 Data integration was done in the following main fields 
1. Analysis of the prevalence of vitamin B12 deficiency in the study population. 
2. Descriptive analysis of clinical manifestations of vitamin b12 deficiency. 
3. Analysis of risk factors for vitamin B12 deficiency. 
4. Descriptive analysis of the level of awareness amongst the study population. 
5. Descriptive analysis of the degree of anxiety and depression within the study 
population using various scales of measurement. 
6. Analysis of correlations between various groups. 
7. Subgroup analysis amongst subjects with pernicious anaemia antibody screens. 
 
Statistical analysis 
 Data entry was done using the Statistical Package for the Social Sciences (SPSS) 
software package (version 16). Descriptive statistics were tabulated using the SPSS 
software. The chi-square test was used for comparison of categorical variables. Odds 
ratios (OR) and confidence intervals (CI) were calculated and a ‘p’ value less than 0.05 
was considered statistically significant. All reported p values are two-sided. Continuous 
variables were handled with the help of the student t tests and ANOVA tests. 
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RESULTS 
 A total of 118 subjects were interviewed of which a total of 10 subjects were 
excluded owing to the fact that they were on vitamin B12 supplementation. Hence a total 
of 108 subjects were included in the analysis. 
 
Demography 
 
Age 
 We recruited a total of 108 patients within the age cut-offs of 18 years and 60 
years. The mean age of the study population was around 41 and half years. The age 
distribution is shown below (refer figure 7). 
 
Figure 7: Distribution of age within the study population 
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Table 3: Age distribution in the population 
 
 
Gender 
 The gender distribution was also uniform. 51.9% of the population were women 
and 48.1% were men. 
 
Region of residence 
 The subjects in this study hailed from almost all over the country. The distribution 
according to the state of residency is shown below. Overall 78.7% of the study population 
was from north India and the remaining 21.3% was from south India – this is the general 
trend in our hospital where we see a major referral bias especially from the north of the 
country (refer figure 8). 
Age groups 
(years) 
Numbers Percentages 
Less than 20 6 5.6 
21-30 16 14.8 
31-40 25 23.1 
41-50 30 27.8 
51-60 31 28.7 
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Figure 8: Distribution of the study population according to the state of residence 
 
Table 4: Distribution of the study population according to the state of residence 
  Frequency Percent 
Andhra Pradesh 6 5.5
Assam 4 3.7
Bihar 14 12.9
Chattisgarh 3 2.7
Gujarat 1 0.9
Jharkhand 28 26
Karnataka 2 1.8
Madhya Pradesh 1 0.9
Nepal 2 1.8
Orissa 6 5.5
Sikkim 1 0.9
Tamil Nadu 10 9.2
Uttar Pradesh 1 0.9
West Bengal 29 26.9
Total 108 100
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Occupation 
 Though there were people from all wakes of life (refer table 5) most of the men 
were businessmen and most of the women were housewives in our study population. 
Table 5: Various professions of our subjects 
  Frequency Percent 
Accountant 1 0.9
Businessman 33 30.7
Chartered Accountant 1 0.9
Clerk 1 0.9
Contractor 1 0.9
Electrical engineer 1 0.9
Farmer 1 0.9
House wife 46 42.8
Maid 1 0.9
Pharmacist 1 0.9
Professor 2 1.8
Serviceman 3 2.8
Social worker 1 0.9
Software engineer 2 1.8
Staff nurse 1 0.9
Stock market trader 1 0.9
Student 8 7.5
Tata Steel Manager 1 0.9
Teacher 2 1.8
Total 108 100
 
Diet 
 We had stratified the dietary practices of the population into three groups: 
a. Those who were pure vegetarians 
b. Those who were vegetarians and consumed milk products as well 
c. Those who were vegetarians and consumed milk products and eggs 
The distribution of the above in our study population is as follows: 
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Study population
5%
89%
6%
Pure vegetarians
Vegetarians consuming milk products
Vegetarians consuming milk products and eggs
 
Figure 9: Dietary practices in the study population 
 
Presenting complaints 
 In our exclusion criteria we had mentioned that people with major co morbidities 
pertaining to the major organ systems were to be excluded. Hence on analysis of the 
reason for presentation to the out patient clinic, we found that 61.1% had presented for 
the sake of a routine health check up without any specific ailments and 13% had 
presented with non specific chronic headache. Thus such a population could arguably be 
generalisable to the entire vegetarian community in India. 
 
Prevalence of vitamin B12 deficiency 
 The characterisation of vitamin B12 deficiency was made according to well 
known standards (75-77). The following three categories were looked at: 
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    * >300 pg/mL (>221 pmol/L) — normal result; cobalamin deficiency is unlikely (i.e., 
probability of 1 to 5 percent) 
    * 200 to 300 pg/mL (148 to 241 pmol/L) — borderline result; cobalamin deficiency 
possible 
    * <200 pg/mL (<148 pmol/L) — low; consistent with cobalamin deficiency 
(specificity of 95 to 100 percent) 
 The distribution of vitamin B12 in our population was as shown in Figure 10. 
 
Figure 10: Distribution of vitamin B12 values within our study population 
 The mean vitamin B12 level in the population was 262.79 pg/mL and as we can 
see from figure 10, the vast majority of the subjects had vitamin B12 levels between 125 
and 250 pg/mL. 
 In our study population, 61.1% had levels below 200, 23.1% had levels between 
200 and 300 and 15.8% had levels above 300. 
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Figure 11: Vitamin B12 levels in the study population 
 The distributions were similar in the female and the male sub groups (refer table 
6). 
Table 6: Vitamin B12 categories among the genders 
Vitamin B12 
category 
Males – 
number(%) 
Females – 
number(%) 
Total 
Low 35(67.3%) 31(55.4%) 66(61%) 
Borderline 7(13.5%) 18(32.1%) 25(23%) 
Normal 10(19.2%) 7(12.5%) 17(16%) 
 
 
Prevalence of folate deficiency 
 According to the biochemical kit for folate, available in our hospital and the 
reference values for that, any value between 3 and 17 ng/mL is considered normal. If we 
look at international reference standards the red cell folate is a better marker of long term 
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folate deficiency than the serum folate per say. However, a serum folate level between 2 
and 4 ng/mL maybe considered as a borderline value. Only 3 out of our 108 subjects had 
a folate level less than 4, and none had a value less than 2. The mean serum folate level in 
our population was 9.97ng/mL and the distribution of the folate levels was as shown 
below in figure 12. 
 
Figure 12: Distribution of folate levels in the study population 
 
 The mean values of folate in the low, borderline and normal vitamin B12 groups 
were 9.0, 9.9 and 13.6 ng/mL. The mean folate level was significantly different between 
the groups by one way ANOVA, with a p value of less than 0.001 (refer table 7). Thus 
the mean folate concentration was significantly higher in the normal B12 group 
compared to the low B12 group. 
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Table 7: Mean folate levels in the three B12 categories [P<0.001 (by ANOVA)] 
 
 There was also a statistically significant correlation between the serum folate 
levels and the vitamin B12 levels throughout the entire population, the Pearson’s 
correlation coefficient being 0.314 (refer figure 13). 
 
Figure 13: Correlation between folate and B12 values in the entire study population 
(p=0.001) 
 Hence as is clear from Figure 14, there was a clear correlation between the 
folate levels and the B12 levels that was statistically significant. Patients with lower 
B12 levels had lower folate levels. 
  
Mean folate level Std. Deviation Std. Error 
95% Confidence Interval for Mean
  Lower Bound Upper Bound 
Low B12 66 9.02 3.12 .384 8.25 9.78
Borderline 
B12 
25 9.97 3.62 .725 8.47 11.47
Normal B12 17 13.66 4.70 1.141 11.24 16.08
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Clinical profile 
 We looked at the clinical profile of the subjects with respect to the following 
parameters: (refer table 8) 
Table 8: Prevalence of various clinical parameters in the three B12 categories 
Clinical parameter Low B12 Borderline B12 Normal B12 
Hyperpigmentation 9.1% 12% 5.9% 
Glossitis 45.5% 36% 41.2% 
SCD 1.5% 0% 0% 
Paraesthesias 42.4% 56% 35.3% 
Diabetes 13.6% 8% 17.6% 
Hypertension 28.8% 12% 17.6% 
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Figure 14: Comparison of clinical parameters among the B12 categories 
 
 
Laboratory profile 
 We had also looked at a few laboratory parameters in the study population. 
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Haemoglobin 
 The mean haemoglobin value in our study population was 12.9 g/dL. The lowest 
haemoglobin value was 8.4 and the highest was 17. 29.6% of the population had a 
haemoglobin value of less than 12 and hence could be classified as anaemic. 
In the low vitamin B12 group the mean haemoglobin level was 12.9 g/dL. 28.8% 
of these people had a haemoglobin value of less than 12. 
In the borderline vitamin B12 group the mean haemoglobin level was 12.6 g/dL. 
36% of these people had a haemoglobin value of less than 12. 
In the normal vitamin B12 group the mean haemoglobin level was 13.2 g/dL. 
23.5% of these people had a haemoglobin value of less than 12. 
Table 9: Haemoglobin values in the three B12 groups 
Parameter Haemoglobin (average 
gm%) 
Haemoglobin <12gm%: 
number(%) 
Low B12 group 12.9 gm% 19(28.8%) 
Borderline B12 group 12.6 gm% 9(36%) 
Normal B12 group 13.2 gm% 4(23.5%) 
 
Mean corpuscular volume 
 The distribution of mean corpuscular volume in the population was as shown in 
the next page (figure 15): 
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Figure 15: The distribution of mean corpuscular volume (MCV) in the study population 
 The mean MCV in the study population was 89.2 fl. The corresponding values in 
the low, borderline and normal B12 categories were 90, 87 and 89 fl, which were no 
different from each other statistically. 19.7% in the low B12 group as opposed to 4% in 
the borderline B12 group had macrocytosis (refer figure 16).  
 
Figure 16: Mean MCV in the three B12 categories (p=0.38) 
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None of the subjects in the normal B12 group had macrocytosis. These values 
were significantly different between the groups by the Chi square test with a p value of 
0.031 (refer table 10). 
Table 10: Mean corpuscular volumes in the three B12 categories (p=0.031) 
Parameter Average MCV fl Number (percentage) of 
patients with macrocytosis 
(MCV >100 fl) 
Low B12 group 90 13 (19.7%) 
Borderline B12 group 87 1(4%) 
Normal B12 group 89 0(0%) 
  
Hence macrocytosis was significantly associated with B12 deficiency and 
indicated the presence of this condition(p=0.031). 
 
Microcytosis 
 In the study population we looked for microcytosis and we found that 11.1% of 
the subjects actually met the definition of microcytosis, which is a mean corpuscular 
volume less than 80 fl (78). Strangely enough, all the microcytosis was in the low and 
borderline vitamin B12 categories with no microcytosis at all in the normal vitamin B12 
category. Statistically however there was no significant differences between the groups 
(refer table 11). 
Table 11: Microcytosis amongst the different B12 categories (p= 0.276) 
 Microcytosis Total 
 Present Absent  
Borderline B12 3(12%) 22 25 
Low B12 9(13.6%) 57 66 
Normal B12 0(0%) 17 17 
Total 12(11.1%) 96 108 
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Predictors of vitamin B12 deficiency 
 One of the objectives of our study was to look for predictors or associations of 
vitamin B12 deficiency. In that regard we studied a few parameters, handling each of 
them in the statistically appropriate methods. 
Age 
 We looked at age to see whether it was significantly associated with vitamin B12 
deficiency. There was no significant difference in the mean ages of the subjects amongst 
the three vitamin B12 categories by ANOVA (p=0.102). 
Diet 
We had classified the subject population into three categories: pure vegetarians 
(vegans), vegetarians who consumed milk products and vegetarians who consumed milk 
products and eggs (eggeterians). The mean vitamin B12 levels in the three groups 
respectively were 145, 270 and 230. There was no statistically significant difference 
between the groups by ANOVA (refer figure 17). 
 
Figure 17: Mean vitamin B12 levels amongst the three diet categories (p=0.623) 
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 We also looked at various laboratory parameters among the three varieties of diet 
consumers – however the numbers were too small for any statistical analysis between 
them (refer table 12). 
Table12: Laboratory parameters amongst the three dietary groups 
Parameter Pure vegetarian 
(N=5) 
Vegetarian with 
milk products 
(N=97) 
Vegetarian with milk 
products and eggs 
(N=6) 
Average B12 value 145.23 270.82 230.98 
Low B12 4(80%) 58(59.8%) 4(66.7%) 
Average MCV 93.44 89.20 91.38 
Macrocytosis 2(40%) 11(11.3%) 1(16.7%) 
Average Hb 13.12 12.92 12.96 
Anaemia (Hb<12) 1(20%) 28(28.9) 3(50%) 
 
Odds ratios and Chi-square tests 
 We used odds ratios and Chi square tests for studying categorical variables (refer 
table 13) as are shown below. For this analysis we assumed people who had vitamin B12 
levels below 200 to be in the “low” vitamin B12 category and all the others to be in the 
“normal” B12 category. The “borderline’ category was not used, both for statistical 
problems and small numbers as well as for the fact that the concept of “borderline” 
vitamin B12 levels is neither very uniform not very well characterised in other studies. 
 Mean corpuscular values of less than or equal to 100fl were categorised as 
normocytic category and anything higher than that was considered as qualifying for 
macrocytosis (43). A folate level cut-off at 9.5 was also taken to look for prediction of 
vitamin B12 deficiency. 
 In our study we had classified the type of drinking water into seven types. For the 
sake of analysis and small numbers we grouped them into “pure water” that included 
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mineral water, aquaguard water and boiled water and “less pure water” that included all 
the rest of the categories for purity of water (tap water, well water, filter water and 
chlorinated water). 
Table 13: Odds ratios of clinical parameters 
Parameter  Numbers (Percentages) 
Odds 
ratio 
Confidence 
intervals P 
  
Low B12 
group 
Borderline 
and normal    
Gender Male 35(67.3%) 17(22.7%) 1.66 0.759-3.633 0.203
 Female 31(55.3%) 25(44.7%)    
Region North 51(60%) 34(40%) 0.8 0.306-2.093 0.649
 South 15(65.2%) 8(34.8%)    
Hyperpigmentation Present 6(60%) 4(40%) 0.95 0.252-3.588 0.94
 Absent 60(61.2%) 38(38.8%)    
Glossitis Present 30(65.2%) 16(34.8%) 1.354 0.615-2.981 0.451
 Absent 36(58.0%) 26(42.0%)    
Paraesthesias Present 28(58.3%) 20(41.7%) 0.811 0.372-1.764 0.596
 Absent 38(63.3%) 22(36.7%)    
Betel use Present 10(66.6%) 5(33.4%) 1.321 0.418-4.178 0.634
 Absent 56(60.2%) 37(39.8%)    
Jarda use Present 8(61.5%) 5(38.5%) 1.021 0.310-3.359 0.973
 Absent 58(61.0%) 37(39.0%)    
PPI use Present 3(37.5%) 5(62.5%) 0.352 0.080-1.560 0.155
 Absent 63(63%) 37(37%)    
H2RB use Present 3(75%) 1(25%) 1.952
0.196-
19.417 0.561
 Absent 63(60.5%) 41(39.5%)    
Metformin use Present 4(57.1%) 3(42.9%) 0.839 0.178-3.950 0.824
 Absent 62(61.3%) 39(38.7%)    
MCV >100 13(92.8%) 1(7.2%) 10.057
1.263-
80.048 0.009
 <100 53(56.3) 41(43.7%)    
Folate <9.5 ng/mL 43(71.6%) 17(29.4%) 2.749 1.238-6.103 0.012
 >9.5 ng/mL 23(47.9%) 25(52.1%)    
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Water 
 We had collected information as to the various sources of drinking water for the 
subjects, to see if the type of water or the purity had any bearing on the levels of vitamin 
B12. The individual numbers in each of the categories of drinking water were very small 
– however on grouping them as mentioned above into two categories “less pure water” 
and “pure water”, there were no statistically significant odds of predicting a vitamin B12 
deficiency (refer table 14). 
 
Table 14: Odds ratio for the type of water: 1.169, 95%Confidence interval: 0.539-2.535, 
p=0.693 
Parameter Low B12 group Borderline and normal 
Less pure water 34(62.9%) 20(37.1%) 
Pure water 32(59.2%) 22(41.8%) 
 
Logistic regression 
 On the basis of the above we did a logistic regression to see which of the above 
factors remain significant on a multivariate analysis. We found that only the mean 
corpuscular volume retains significance on a multivariate model, with a p value of 0.048 
(refer table 15).  
Table 15: Logistic regression 
  Std Error Deg of freedom P value Risk 
Age 0.01 1 0.59  
Sex 0.42 1 0.25  
Folate level 0.43 1 0.11  
MCV 1.07 1 0.04 8.4
PPI 0.84 1 0.2  
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 Hence, on a multivariate analysis, a patient with macrocytosis (MCV>100fl) 
had an 8 fold risk of B12 deficiency compared to a patient with normocytosis. 
 
Awareness regarding vitamin B12 deficiency 
 As a part of the clinical interview the subjects had been asked three questions to 
assess the level of their awareness regarding vitamin B12 deficiency (refer Annexure 2). 
Only 4 people out of the 108 that were finally included in the analysis, were actually 
aware of a condition known as vitamin B12 deficiency. Only one of them actually knew 
that being a vegetarian made them prone to vitamin B12 deficiency, and only that same 
person knew that vegetarians might actually have to take supplemental vitamins to 
prevent vitamin B12 deficiency. Hence the awareness regarding this condition is 
extremely poor, almost to the extent of being non existent. 
 
Anxiety and depression studies 
 During the clinical interview we had done an assessment of the prevalence of 
anxiety and the depression within the study population with the help of two widely used 
scoring systems – namely the General Health Questionnaire – 12, and the Hospital 
Anxiety and Depression Score. Summarised below are the results. 
 
General Health Questionnaire – 12 (GHQ-12) 
 The GHQ-12 theoretically can have scores between 0 and 36, with scores upto 15 
being taken as normal, 16-20 suggesting evidence of distress and 21 and above signifying 
severe distress. 
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 The mean GHQ-12 score in our population was 17.70 and the distribution of the 
scores is as below. 
 
 The mean GHQ-12 scores in the low, borderline and normal B12 categories were 
17.62, 18.00 and 17.59 respectively. Percentages of subjects with GHQ-12 scores 
signifying normal score, evidence of distress and severe distress among the three B12 
categories are shown below (refer figure 18). 
 
General Health Questionnaire
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Normal B12
 
Figure 18: GHQ-12 grades in the three B12 categories 
 
 Overall, in the entire study population, the mean vitamin B12 levels in the three 
GHQ-12 categories namely “normal”, “evidence of distress” and “extreme distress” were 
258.79, 256.76 and 274.49. There was no statistically significant difference between the 
groups (p=0.966 by ANOVA). 
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 We also looked at whether the GHQ-12 scores correlated with the vitamin B12 
values within the entire study population – there was no such significant correlation (refer 
figure 19). 
 
Figure 19: Correlation between GHQ-12 scores and B12 levels in the entire population 
(p=0.973) 
 
Hospital Anxiety and Depression Score – Anxiety (HADS-A) 
 The HADS-A theoretically can have scores between 0 and 21, with scores upto 7 
being taken as normal, 8-10 suggesting borderline abnormal and 11 and above signifying 
abnormal scores. 
 The mean HADS-A score in our population was 7.45 and the distribution of the 
scores is as below. 
The mean HADS-A scores in the low, borderline and normal B12 categories were 
7.77, 7.76 and 5.76 respectively. Percentages of subjects with HADS-A scores signifying 
 69
normal , borderline abnormal and abnormal scores, among the three B12 categories are 
shown in Figure 20. 
Hospital Anxiety and Depression Score - Anxiety
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Figure 20: HADS - A grades in the three B12 categories 
Overall, in the entire study population, the mean vitamin B12 levels in the three 
HADS-A categories namely “normal”, “borderline abnormal” and “abnormal” were 
278.89, 237.53 and 252.33. There was no statistically significant difference between the 
groups (p=0.847 by ANOVA). 
 We also looked at whether the HADS-A scores correlated with the vitamin B12 
values– there was no such significant correlation (refer figure 21). 
 
Figure 21: Correlation between HADS-A scores and B12 levels (p=0.402) 
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Hospital Anxiety and Depression Score – Depression (HADS-D) 
 The HADS-D theoretically can have scores between 0 and 18, with scores upto 7 
being taken as normal, 8-10 suggesting borderline abnormal and 11 and above signifying 
abnormal scores. The mean HADS-D score in our population was 3.84 and the 
distribution of the scores is as below. 
 The mean HADS-D scores in the low, borderline and normal B12 categories were 
3.92, 3.96 and 3.35 respectively. Percentages of subjects with HADS-D scores signifying 
normal, borderline abnormal and abnormal scores, among the three B12 categories are 
shown below. 
 Overall, in the entire study population, the mean vitamin B12 levels in the three 
HADS-D categories namely “normal”, “borderline abnormal” and “abnormal” were 
260.5, 292.01 and 207.10. There was no statistically significant difference between the 
groups (p=0.819 by ANOVA). 
 We also looked at whether the HADS-D scores correlated with the vitamin B12 
values within the entire study population – there was no such significant correlation (refer 
figure 23). 
Hospital Anxiety and Depression Score - Depression
78%
17%
5%
72%
16%
12%
82%
18%
0%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Normal Borderline abnormal Abnormal
Low B12
Borderline B12
Normal B12
 
Figure 22: HADS-D grades in the three B12 categories 
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Figure 23: Correlation between HADS-D scores and B12 levels in the entire population 
(p=0.732) 
 Hence none of the depression or anxiety scores showed any correlation between 
the levels of distress and the levels of vitamin B12. 
 
Pernicious anaemia antibody screens 
 We had performed pernicious anaemia antibody screens amongst a small sub 
group of our subjects. In total we did 23 pernicious anaemia antibody screens (17 
amongst vitamin B12 deficient and 6 amongst vitamin B12 non deficient, i.e. with B12 
levels above 200). In total we had 10 positive screens and 13 negative screens. Intrinsic 
factor antibody was positive in 4 cases, parietal cell antibody was positive in 4 cases and 
both were positive in 2 cases. 47% of the pernicious anaemia antibody screens were 
positive in the low B12 group as opposed to 33% in the normal group. Owing to the small 
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numbers and the nature of the sub group and the uncertainty of random sampling no 
statistical analysis could be performed with this data (refer table 16). 
Table 16: Pernicious anaemia antibody screens 
Pernicious anaemia antibody screens versus Vitamin B12 levels 
Count     
  Vitamin B12 levels 
Total   Low Normal 
Pernicious anaemia 
antibody(PAA) screen 
Positive 8 2 10
Negative 9 4 13
Total 17 6 23
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DISCUSSION 
 This was a cross-sectional study among vegetarians between the age groups of 18 
and 60 years visiting the out patient department of a tertiary level hospital in South India. 
 
Population profile 
 We recruited 108 patients in all, that hailed from all over the country. People from 
the north were more than those from the south – a trend quite common in our hospital 
owing to the referral bias. Men and women were almost equal in number and the overall 
age distribution appeared uniform. All subjects were Hindus. We had excluded the 
elderly age group and the paediatric age group. Owing to this being a hospital based 
study with all its inherent biases the question of generalisability to the community at large 
is debatable. On the other hand we had excluded patients with any major co morbidity 
and analysis showed that 61.1% of people had come for a health check up with no 
specific complaints. Only 13% had diabetes and 23% had hypertension. In view of the 
above, the selected population appears fairly well and fit, akin to the expected selection in 
a community based population – making the possibility of extrapolating such a result to 
the community setting, acceptable. 
 
Prevalence of vitamin B12 deficiency 
 The prevalence of vitamin B12 deficiency (level less than 200), amongst overall 
healthy patients presenting mainly for a check up was 61%. Borderline B12 levels 
(between 200 and 300), were seen in 23% more people. Hence 84% of the population had 
levels that were either borderline or low, and only 16% were absolutely normal. This is 
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comparable to the community study by Yajnik et al (15), in which 67% of the population 
had a low B12 level. 
 Hence from this data it is clear that absolutely low levels of vitamin B12 among 
vegetarians, are rampant in the country, and the percentages rise even higher if we look at 
borderline B12 levels. We know from previous studies that even with low normal B12 
levels (i.e. in the borderline levels) there are biochemical changes that initiate within the 
body that can potentially be damaging. Hence almost 84% of the population studied here 
are at a risk for possible end organ damage. This is a large number and it remains to be 
seen if the same trend is being duplicated in other parts of the country as well. 
 
Mean corpuscular volume 
 Macrocytosis was significantly more frequent in the low vitamin B12 category. 
13% of the population had an MCV of 100fl or more (19% amongst deficient people, 4% 
amongst borderline B12 people and none amongst people with normal B12 levels).This is 
starkly in contrast to Yajnik’s study (15), where only 2% of the study population had 
macrocytosis. Also 11.1% had an MCV of less than 80fl, which is the classical cut-off for 
indicating microcytosis (78). There might have been a sizeable proportion within our 
study population that may have had a subclinical iron deficiency leading to a dimorphic 
blood picture that might have skewed the percentage of macrocytosis. Interestingly 
13.6% of the subjects in the low B12 category and 12% in the borderline B12 category 
had microcytosis – whereas in the normal B12 category there were absolutely no subjects 
with microcytosis. This only strengthens the possibility of coexisting sub-clinical iron 
deficiency in the low and borderline B12 categories. Iron studies and ferritin may have 
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been useful parameters for monitoring in this situation, that could be done in subsequent 
studies. Malnutrition contributing to the above would be unlikely, as most of the subjects 
were from a well to do socioeconomic background. In view of the above possibility of 
coexisting sub-clinical iron deficiency that simply cannot be attributed to a vegetarian 
dietary intake, malabsorbtive syndromes could be a clinical differential in this subgroup 
of people that needs to be clinically explored.  
 
Prevalence of folate deficiency 
 Only three out of our 108 subjects had a folate level of less than 4 and none had a 
level below 3. Hence effectively there was almost zero prevalence of folate deficiency in 
our study population. Folate deficiency may not always coexist with B12 deficiency, their 
physiology and metabolism being distinct. Serum folate levels typically take very short 
whiles to normalise – for example a single meal maybe enough to normalise serum folate 
even if tissue stores are low. Hence it has been argued before that red cell folate is a 
better indicator of tissue folate stores. Furthermore folate is obtained from greens and not 
solely obtained from animal products. Folate deficiency is typically seen in subjects who 
are chronic alcoholics and those who are on medications that might antagonise folate 
metabolism – none of those scenarios where prevalent in our study population. Hence it 
was not surprising that we did not pick up any folate deficiency.  
The mean folate level in our population was 9.97ng/mL and the distribution was 
uniform. Within the normal levels of folate, there seemed to be a distinct correlation 
between the folate levels and the B12 levels, and a folate level less than 9.5 predicted 
B12 deficiency on a univariate analysis. The significance of this finding is not clear, 
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though the possibility of a malabsorptive disorder (given that associated iron deficiency 
and microcytosis probably also exists in this population), might be considered to explain 
the observation. 
 
Clinical profile 
 Glossitis, paraesthesias and pallor where the most common clinical features 
amongst the subjects with low vitamin B12 levels. Hyperpigmentation and jaundice 
where seen to be less frequent in the B12 deficient group. Only one patient in the low 
B12 category had clinical features commensurate with a diagnosis of subacute combined 
degeneration of the cord. No clinical feature could actually predict low B12 levels in the 
population. Diabetes and hypertension were not very frequent among the groups. Nobody 
had any other major co morbidity. Psychiatric symptoms have been analysed separately 
in a later section. 
 
Haemoglobin 
 Overall the study group looked well preserved with a mean haemoglobin value of 
12.9 g/dL. Mean haemoglobin levels in the three B12 categories appeared to be similar. 
The population haemoglobin distribution also appeared Gaussian. About 29% had 
haemoglobin levels below 12. This is again another point to indicate that the population 
chosen was not majorly diseased as would be expected in a hospital population survey – 
indicating that probably the results could be extrapolated to the community. In the study 
by Yajnik et al (15) the quoted figures for anaemia (in that study haemoglobin less than 
13.5 had been defined as anaemia), were comparable to ours. 
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Predictors or associations of vitamin B12 deficiency 
 We studied various clinical parameters, drug exposure, water source and 
biochemicals to see whether the presence of any of them could significantly predict 
vitamin B12 deficiency. The univariate analyses have been given in a previous section. 
There were not many people in our study population who had been exposed to the drugs 
that we studied, hence probably the numbers were not really adequate. On the univariate 
analysis only two factors namely an MCV of greater than 100fl and a folate level of less 
than 9.5ng/mL significantly predicted a vitaminB12 level of less than 200. When we 
adjusted the risk ratios for various coviariates using logistic regression, only an MCV of 
greater than 100fl actually predicted a vitamin B12 level of less than 200 – all the rest of 
the factors were insignificant on the multivariate analysis. This may not be the true 
picture in terms of risk factor analysis principally for two reasons – firstly this study was 
not really powered towards looking into causal associations and secondly the numbers in 
each of these subgroups were probably not large enough to achieve statistically 
significant results. 
 
Awareness 
 An extremely low level of awareness of the vegetarian population under study, 
regarding this condition of vitamin B12 deficiency, was clearly apparent from the 
analysis of the questionnaires. However it must be remembered that this study had 
excluded people (10 people to be exact) on any kind of vitamin supplementation, and that 
excluded population might have had a better awareness of the condition. To our 
knowledge this aspect has not been studied previously. Given the fact that the prevalence 
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of the condition is high and vegetarianism is common in India (6), it becomes all the 
more important to assess the awareness of this condition in the community, for public 
health benefits. There may be important clinical and therapeutic implications of this in 
the field of prevention of this condition. This maybe an important issue to look into, in 
future studies. 
 
Anxiety and depression studies 
 One important aspect of this study was to look at the neuropsychiatric 
symptomatology in our study population. Though neuropsychiatric manifestations have 
been described in the B12 deficient, there is not much data as to the patterns and 
prevalences of these symptoms. With both our screening tools (i.e. the General Health 
Questionnaire – 12, and the Hospital Anxiety and Depression Score), we found a high 
level of anxiety and depression in our study population. Unfortunately there were no 
major statistical differences between the low, borderline and normal B12 categories in 
terms of characterization and degree of neuropsychiatric symptoms – none of them were 
found to be able to significantly predict B12 deficiency. Correlation studies between the 
anxiety and depression scores and the B12 levels in the population were not found to be 
statistically significant. The cause for this negative result is probably three things: 
A] Being a hospital cohort the general level of anxiety among the study population would 
have been expected to be higher than in a community cohort ( to keep in mind, most of 
the subjects had voluntarily come for check ups – making a point that a certain degree of 
anxiety would have triggered this overt health seeking behaviour) 
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B] The study was again not really powered to pick up differences in the neuropsychiatric 
manifestations between the three different B12 categories 
C] Only screening tests were used to gauge neuropsychiatric symptoms – perhaps 
detailed DSM IV or ICD-10 criteria for anxiety and depression would be necessary to 
pick out statistically significant differences between the various groups 
 However overall, this study does tell us that the level of neuropsychiatric 
symptoms in this population is high, and would possibly be a pertinent point for further 
investigations in the future. 
 
Pernicious anaemia antibody screens 
 Owing to various constraints we were able to perform pernicious anaemia 
antibody screens in only few limited numbers among our subjects. Of our 23 tests, 10 
results were positive, of which 5 had positivity for intrinsic factor antibody. We did a 
univariate cross-tabulation between pernicious anaemia antibody screens and vitamin 
B12 levels in that small subgroup of 23 that did not reveal any statistically significant 
result. Numbers obviously were a major problem here. However this high level of 
positivity with the antibody screens brings us to the point of whether there is hidden 
pernicious anemia, or for that matter the autoimmune polyglandular syndromes, within 
this population. We understand that these antibodies have false positives and we have not 
done gastric biopsies for any of our patients, to claim anything very significant – but still 
given the unusually high rate of positivity for these markers, further investigations are 
probably of the order to probe deeper into this matter. 
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LIMITATIONS 
 
 There were a few important limitations to this study: 
A] The hospital based population selection has its inherent biases and problems of 
extrapolation of the results to the community. 
B] The design of the study being cross-sectional, analysis of risk factors and drawing up 
associations including causal associations might not be without its problems. 
C] The small numbers may not have been adequate to bring out the statistical 
significances of certain studied factors. 
D] The high rates of anxiety and depression may have been owing to the inherent 
selection bias of this hospital based cohort. The screening tools may also have 
contributed to this. 
E] The analysis of pernicious anaemia antibody screens was not complete owing to 
various constraints. 
 
 
 
 
 
 
 
 81
CONCLUSIONS 
 This was a cross sectional study among vegetarian out patients where we found 
the following: 
A] There was a high prevalence of vitamin B12 deficiency (61%) in the study population. 
Another 23% had borderline vitamin B12 levels. Most of them were not overtly 
symptomatic. 
B] The most common clinical features were glossitis and paresthesias. Subacute 
combined degeneration of the spinal cord was rare.  
C] Macrocytosis (MCV>100fl) was seen in 19.7% of B12 deficient patients and in 4% of 
the borderline B12 group. An MCV higher than 100fl and a folate level less than 
9.5ng/mL predicted vitamin B12 deficiency.  Also, the folate levels correlated very well 
with the vitamin B12 levels. 
D] Etiology of vitamin B12 deficiency in the population is unlikely to be purely dietary 
and could be multi-factorial including malabsorption and pernicious anaemia. 
E] Awareness about B12 deficiency was extremely low. 
F] There was a high prevalence of neuropsychiatric symptoms in the entire study 
population – there were no significant differences between the B12 categories in terms of 
anxiety and depression scores.  
G] Within a small subgroup of the study population, an unusually high level of pernicious 
anaemia antibody positivity was found, that could not be adequately handled statistically 
owing to small numbers. 
 Overall, there were a number of clinical and statistical possibilities that emerged 
from this small study, that require further investigation in larger studies in the future. 
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Annexures 
 
Annexure 1 
 
INFORMED CONSENT 
 
This is a study that is being done to look at the prevalence of Vitamin B12 deficiency and 
the clinical manifestations and the risk factors associated with this condition. 
Should I agree to participate in this study I will have to undergo the following: 
a. When I come to the OPD for the very first time I will be asked some questions, 
some about my symptoms and some about things like the type of water I use, 
whether I chew pan, whether I take any other medications etc.  
b. Following this I will have a physical examination. 
c. Following this I will be required to fill a general health questionnaire. 
d. Following this I will be given a few blood tests to do. 
 
I will not have to undergo any special procedure if I am consenting for this study. I will 
not incur any extra costs for this and my treatment will be no different from any other 
person with a similar disease. 
I understand that my clinical data will be available to all the people involved in the 
research but my name will be held confidential. Confidentiality of patient information 
will be maintained. 
I understand that my participation is voluntary, and I have full right to withdraw from this 
study at any point without giving any reason. 
In the event that I am detected to be Vitamin B12 deficient, I will be appropriately 
advised regarding the treatment for the condition. 
I have read the contents of this page and have had ample opportunities to ask questions 
about it. I understand the contents of this page and I hereby agree to give my consent 
towards my participation in this study. 
 
Signature of the subject:    Signature of the investigator: 
Name of the subject:     Name of the investigator: 
Date:       Date: 
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Annexure 2 
 
RAW DATA COLLECTION SHEET 
 
 
Name of the subject: 
 
Age: 
 
State: 
 
Relegion: 
 
Diet: pure vegetarian / vegetarian and milk products / vegetarian and milk products and 
egg 
 
 
 
 
 
Clinical manifestations: 
 
1. Pallor – yes / no 
2. Jaundice – yes / no 
3. Hyperpigmentation – yes / no 
4. Glossitis – yes / no 
5. Sub acute combined degeneration* – yes / no 
6. Peripheral neuropathy – yes / no 
7. Neuro psychiatric symptoms – yes / no 
(General Health Questionnaire) 
 
 
 
 
Comorbidities: 
 
1. Diabetes – yes / no 
2. Hypertension – yes / no 
3. Ischemic heart disease – yes / no 
4. Cerebrovascular disease – yes / no 
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Lab parameters: 
 
1. B12 –  
2. Folate –  
3. MCV –  
4. Haemoglobin – 
5. Blood picture – macrocytosis present / absent 
6. Pernicious anaemia antibody screen (any of the two antibodies) – positive / 
negative 
7. Homocysteine – high / normal / low 
8. Upper GI scopy -  
 
 
 
Type of water used for drinking (for more than 50% of the time in the last one year): 
 
 
 
Mineral water / aqaguard water / boiled water / chlorinated water / tap water / filter water 
/ well water 
 
 
 
Use of betel leaves (at least one per day for the last one year): yes / no 
 
 
 
Use of jarda (at least once a day for the last one year): yes / no 
 
 
 
Do you know of any extra food supplementation that you may require for being a 
vegetarian – yes / no 
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Do you know of this condition called Vitamin B12 deficiency – yes / no 
 
 
 
Do you know that you are prone to developing Vitamin B12 deficiency – yes / no 
 
 
 
Use of the following drugs (at least once a week for the last one year) 
 
1. Aspirin – yes / no 
2. Proton pump inhibitors – yes / no 
3. H2 receptor blockers – yes / no 
4. Metformin – yes / no 
 
*As evidenced by signs of both the pyramidal tracts and the posterior columns 
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Annexure 3 
 
Hospital Anxiety and Depression Scale (HADS) 
Patients are asked to choose one response from the four given for each 
interview.   They should give an immediate response and be dissuaded 
from thinking too long about their answers.  The questions relating to 
anxiety are marked "A", and to depression "D".  The score for each answer 
is given in the right column.  Instruct the patient to answer how it currently 
describes their feelings. 
  
A I feel tense or 'wound up':  
  Most of the time 3
  A lot of the time 2
  From time to time, occasionally 1
  Not at all 0
  
  
  
D I still enjoy the things I used to enjoy:   
 Definitely as much 0
 Not quite so much 1
 Only a little 2
 Hardly at all 3
A 
I get a sort of frightened feeling 
as if something awful is about 
to happen: 
  
  Very definitely and quite badly 3
  Yes, but not too badly 2
  A little, but it doesn't worry me 1
  Not at all 0
D I can laugh and see the funny side of things:   
 As much as I always could 0
 Not quite so much now 1
 Definitely not so much now 2
 Not at all 3
A Worrying thoughts go through my mind:   
  A great deal of the time 3
  A lot of the time 2
  From time to time, but not too often 1 
  Only occasionally 0
A I can sit at ease and feel relaxed:   
 Definitely 0
 Usually 1
 Not Often 2
 Not at all 3
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D I feel as if I am slowed down:  
  Nearly all the time 3
  Very often 2
  Sometimes 1
  Not at all 0
A 
I get a sort of frightened feeling 
like 'butterflies' in the 
stomach: 
  
 Not at all 0
 Occasionally 1
 Quite Often 2
 Very Often 3
D I have lost interest in my appearance:   
  Definitely 3
  I don't take as much care as I should 2 
  I may not take quite as much care 1 
  I take just as much care as ever 0
A I feel restless as I have to be on the move:   
 Very much indeed 3
 Quite a lot 2
 Not very much 1
 Not at all 0
D I look forward with enjoyment to things:   
  As much as I ever did 0
  Rather less than I used to 1
  Definitely less than I used to 2
  Hardly at all 3
A I get sudden feelings of panic:  
 Very often indeed 3
 Quite often 2
 Not very often 1
 Not at all 0
D I can enjoy a good book or radio or TV program:   
  Often 0
  Sometimes 1
  Not often 2
  Very seldom 3
  
Scoring (add the As = Anxiety.  
Add the Ds = Depression).  The 
norms below will give you an 
idea of the level of Anxiety and 
Depression. 
  
 0-7 = Normal  
 8-10 = Borderline abnormal  
 11-21 = Abnormal  
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Reference: Zigmond and Snaith (1983) 
Annexure 4 
 
GENERAL HEALTH QUESTIONNAIRE (GHQ) - 12 
 
General Health Questionnaire 
Have you recently: 
 
1. Been able to concentrate on what you’re doing? 
Better than usual Same as usual Less than usual Much less than usual 
 
2. Lost much sleep over worry? 
Not at all No more than usual Rather more than usual Much more than usual 
 
3. Felt you were playing a useful part in things? 
More so than usual Same as usual Less useful than usual 
Much less than 
usual 
 
4. Felt capable of making decisions about things? 
More so than usual Same as usual Less useful than usual 
Much less than 
usual 
 
5. Felt constantly under strain? 
Not at all No more than usual Rather more than usual Much more than usual 
 
6. Felt you couldn’t overcome your difficulties? 
Not at all No more than usual Rather more than usual Much more than usual 
 
7. Been able to enjoy your normal day-to-day activities? 
More so than usual Same as usual Less useful than usual 
Much less than 
usual 
 
8. Been able to face up to your problems? 
More so than usual Same as usual Less useful than usual 
Much less than 
usual 
 
9. Been feeling unhappy and depressed? 
Not at all No more than usual Rather more than usual Much more than usual 
 
10. Been losing confidence in yourself? 
Not at all No more than usual Rather more than usual Much more than usual 
 
11. Been thinking of yourself as a worthless person? 
Not at all No more than usual Rather more than usual Much more than usual 
 
12. Been feeling reasonably happy, all things considered? 
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More so than usual Same as usual Less useful than usual 
Much less than 
usual 
 
Scoring (General Health Questionnaire -12) – Likert Scale 0, 1, 2, 3 from left to right.  
12 items, 0 to 3 each item  
Score range 0 to 36.  
Scores vary by study population. Scores about 11-12 typical.  
Score >15 evidence of distress, Score >20 suggests severe problems and psychological 
distress 
 
